A clinical trial to assess the benefit of Opicapone (OPC) add-on to levodopa-carbidopa intestinal gel (LCIG) in different phenotypes of Parkinson's Disease (PD) patients
Latest Information Update: 06 Nov 2022
At a glance
- Drugs Levodopa/carbidopa (Primary) ; Opicapone (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
Most Recent Events
- 06 Nov 2022 New trial record
- 18 Sep 2022 Results presented at the 26th International Congress of Parkinson's Disease and Movement Disorders